Gamble, Carrol

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ

COVID-19 Clinical Research StudiesCOVID-19 and healthcare impacts

Cited by 3,481

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias

Dwan, K., Altman, D. G., Arnaiz, J. A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P. J., Von Elm, E., Gamble, C., et al. (2008) · PLoS ONE

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 1,546

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews

Kirkham, J. J., Dwan, K. M., Altman, D. G., Gamble, C., Dodd, S., Smyth, R., & Williamson, P. R. (2010) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 1,133

Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias — An Updated Review

Dwan, K., Gamble, C., Williamson, P. R., Kirkham, J. J., & the Reporting Bias Group (2013) · PLoS ONE

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 1,127

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., Chadwick, D. W., Cramp, C., Cockerell, O. C., Cooper, P. N., Doughty, J., et al. (2007) · The Lancet

Epilepsy research and treatmentPharmacological Effects and Toxicity Studies

Cited by 976

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Dejnirattisai, W., Huo, J., Zhou, D., Zahradník, J., Supasa, P., Liu, C., Duyvesteyn, H. M. E., Ginn, H. M., Mentzer, A. J., Tuekprakhon, A., et al. (2022) · Cell

SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches

Cited by 930

Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies

Avery, K. N. L., Williamson, P. R., Gamble, C., O'Connell Francischetto, E., Metcalfe, C., Davidson, P., Williams, H., & Blazeby, J. M. (2017) · BMJ Open

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 575

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials

Gamble, C., Krishan, A., Stocken, D., Lewis, S., Juszczak, E., Doré, C., Williamson, P. R., Altman, D. G., Montgomery, A., Lim, P., et al. (2017) · JAMA

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 536

Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities

Bower, P., Brueton, V., Gamble, C., Treweek, S., Smith, C. T., Young, B., & Williamson, P. (2014) · Trials

Ethics in Clinical ResearchStatistical Methods in Clinical Trials

Cited by 369

Comparison of protocols and registry entries to published reports for randomised controlled trials

Dwan, K., Altman, D. G., Cresswell, L., Blundell, M., Gamble, C. L., & Williamson, P. R. (2011) · Cochrane Database of Systematic Reviews

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 243

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Pairo-Castineira, E., Rawlik, K., Bretherick, A. D., Qi, T., Wu, Y., Nassiri, I., McConkey, G. A., Zechner, M., Klaric, L., Griffiths, F., et al. (2023) · Nature

Genetic Associations and EpidemiologyCOVID-19 Clinical Research Studies

Cited by 225

Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists

Smyth, R. M. D., Kirkham, J. J., Jacoby, A., Altman, D. G., Gamble, C., & Williamson, P. R. (2011) · BMJ

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 220

Selective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews

Saini, P., Loke, Y. K., Gamble, C., Altman, D. G., Williamson, P. R., & Kirkham, J. J. (2014) · BMJ

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 209

Outcome selection bias in meta-analysis

Williamson, P. R., Gamble, C., Altman, D. G., & Hutton, J. L. (2005) · Statistical Methods in Medical Research

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 188

Evidence for the Selective Reporting of Analyses and Discrepancies in Clinical Trials: A Systematic Review of Cohort Studies of Clinical Trials

Dwan, K., Altman, D. G., Clarke, M., Gamble, C., Higgins, J. P. T., Sterne, J. A. C., Williamson, P. R., & Kirkham, J. J. (2014) · PLoS Medicine

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 187

Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews

Kirkham, J. J., Altman, D. G., Chan, A.-W., Gamble, C., Dwan, K. M., & Williamson, P. R. (2018) · BMJ

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 144

Identification and impact of outcome selection bias in meta‐analysis

Williamson, P. R., & Gamble, C. (2005) · Statistics in Medicine

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 132

Reporting of harms data in RCTs: a systematic review of empirical assessments against the CONSORT harms extension

Hodkinson, A., Kirkham, J. J., Tudur-Smith, C., & Gamble, C. (2013) · BMJ Open

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 111

The use of systematic reviews in the planning, design and conduct of randomised trials: a retrospective cohort of NIHR HTA funded trials

Jones, A. P., Conroy, E., Williamson, P. R., Clarke, M., & Gamble, C. (2013) · BMC Medical Research Methodology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 72

Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials

Wang, Y., Keitz, S., Briel, M., Glasziou, P., Brignardello-Petersen, R., Siemieniuk, R. A. C., Zeraatkar, D., Akl, E. A., Armijo-Olivo, S., Bassler, D., et al. (2025) · BMJ

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 60

Selective reporting of outcomes in randomised controlled trials in systematic reviews of cystic fibrosis

Dwan, K., Kirkham, J. J., Williamson, P. R., & Gamble, C. (2013) · BMJ Open

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 55

Prospective reporting of statistical analysis plans for randomised controlled trials

Hemming, K., Kearney, A., Gamble, C., Li, T., Jüni, P., Chan, A.-W., & Sydes, M. R. (2020) · Trials

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 34

Exploring the role and function of trial steering committees: results of an expert panel meeting

Harman, N. L., Conroy, E. J., Lewis, S. C., Murray, G., Norrie, J., Sydes, M. R., Lane, J. A., Altman, D. G., Baigent, C., Bliss, J. M., et al. (2015) · Trials

Ethics in Clinical ResearchStatistical Methods in Clinical Trials

Cited by 33

Application and investigation of a bound for outcome reporting bias

Williamson, P. R., & Gamble, C. (2007) · Trials

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 26